FDA approves first ever T-cell receptor gene therapy from Adaptimmune, Servier’s brain tumor pill
This week, Adaptimmune clinched gold when it secured the first-ever US Food and Drug Administration (FDA) approval for a T-cell...
Impressions : 1171

